HeXun Biosciences Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	290.83	286.42	130.57	49.47	-
Revenue Growth (YoY)	14.01%	119.36%	163.94%	-	-
Cost of Revenue	28.15	25.75	16.84	4.86	-
Gross Profit	262.67	260.67	113.73	44.61	-
Selling, General & Admin	50.62	39.57	33.14	14.23	5.95
Research & Development	84.76	65.37	53.22	39.36	44.71
Operating Expenses	135.38	104.94	86.36	53.59	50.66
Operating Income	127.29	155.73	27.37	-8.98	-50.66
Interest Expense	-1.11	-1.18	-1.85	-1.64	-1.57
Interest & Investment Income	6.1	4.41	2.79	0.46	0.03
Currency Exchange Gain (Loss)	-2.95	-0.79	0.53	0.02	-
Other Non Operating Income (Expenses)	3.61	3.3	4.7	4.93	9.01
EBT Excluding Unusual Items	132.95	161.48	33.54	-5.21	-43.19
Gain (Loss) on Sale of Assets	-1.62	-0.01	-0.05	0.02	0.2
Pretax Income	131.35	161.47	33.49	-5.19	-42.99
Income Tax Expense	19.05	14.25	-	-	-
Net Income	112.31	147.22	33.49	-5.19	-42.99
Net Income to Common	112.31	147.22	33.49	-5.19	-42.99
Net Income Growth	-15.76%	339.62%	-	-	-
Shares Outstanding (Basic)	46	46	45	38	31
Shares Outstanding (Diluted)	46	46	45	38	31
Shares Change (YoY)	0.06%	1.61%	20.81%	22.92%	-
EPS (Basic)	2.44	3.20	0.74	-0.14	-1.41
EPS (Diluted)	2.44	3.20	0.74	-0.14	-1.41
EPS Growth	-15.76%	332.90%	-	-	-
Free Cash Flow	156.22	83.63	22.42	10	-35.5
Free Cash Flow Per Share	3.39	1.82	0.49	0.27	-1.16
Gross Margin	90.32%	91.01%	87.10%	90.18%	-
Operating Margin	43.77%	54.37%	20.96%	-18.15%	-
Profit Margin	38.62%	51.40%	25.65%	-10.49%	-
Free Cash Flow Margin	53.71%	29.20%	17.17%	20.22%	-
EBITDA	150.53	175.88	43.12	2.58	-41.87
EBITDA Margin	51.76%	61.41%	33.03%	5.21%	-
D&A For EBITDA	23.24	20.15	15.75	11.56	8.8
EBIT	127.29	155.73	27.37	-8.98	-50.66
EBIT Margin	43.77%	54.37%	20.96%	-18.15%	-
Effective Tax Rate	14.50%	8.82%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.